Menu
Sign In Search Podcasts Libraries Charts People & Topics Add Podcast API Blog Pricing

Chamath Palihapitiya

πŸ‘€ Speaker
See mentions of this person in podcasts
31314 total appearances
Voice ID

Voice Profile Active

This person's voice can be automatically recognized across podcast episodes using AI voice matching.

Voice samples: 16
Confidence: High

Appearances Over Time

Podcast Appearances

All-In with Chamath, Jason, Sacks & Friedberg
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

OpenAI, even if they're not at a billion, they're still at 900 million weekly users, which is well ahead of whatever Claude is at.

818.066 View full episode β†’
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

I think Claude is like probably sub 100 million sacks, you may know.

826.959 View full episode β†’
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

And then Gemini is probably closer to them at 700 to a billion, somewhere in that range, probably pretty neck and neck with OpenAI.

829.603 View full episode β†’
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

So, you know, the consumer market looks like it's trending towards a chat GPT slash Google fight for first place and second place, and then probably anthropic in third place.

838.06 View full episode β†’
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

And maybe Elon emerges and takes off enabled by his compute capacity.

848.893 View full episode β†’
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

And then the enterprise market is a little bit of a different story.

852.978 View full episode β†’
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

And that's its own market, which is kind of anthropic.

855.982 View full episode β†’
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

or probably Google in the lead, actually, if you look at all the Vertex use, Google claims that 75% of GCP customers are active users of Vertex.

858.665 View full episode β†’
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

So there's probably a pretty sizable market share that Google's captured on the enterprise side as well.

868.535 View full episode β†’
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

This is also probably why Google stock has absolutely ripped over the last couple of months is they're literally in first place or fighting for first place in enterprise and consumer.

874.361 View full episode β†’
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

But I still think that there's a lot of opportunity to Chamath's point about the compute and energy capacity constraints in improving how we actually scale and deploy models in both the enterprise and the consumer setting.

884.517 View full episode β†’
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

And it is such early days.

896.781 View full episode β†’
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

And I just want to highlight this paper that came out.

898.364 View full episode β†’
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

from MIT, from these two scientists.

900.869 View full episode β†’
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

And these guys published a paper on pruning techniques and neural networks.

904.433 View full episode β†’
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

This paper showed that you could actually reduce the size of these networks by 90% and get the same accuracy out by pruning very large models down to smaller models.

908.677 View full episode β†’
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

And then you can make a selection on which model to run for inference.

919.908 View full episode β†’
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

And by doing this, you can actually reduce inference costs by 10x, you can get 10x the output

923.191 View full episode β†’
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

per energy unit that goes into the data center with no loss of accuracy.

928.797 View full episode β†’
All-In with Chamath, Jason, Sacks & Friedberg
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze

And so it's a really interesting call it algorithmic technique that can be applied to the existing large models to actually make them much lower energy use.

933.703 View full episode β†’